A previous study by Okamoto and colleagues found that adiponectin has an antiatherogenic effect [3], and other studies have associated adiponectin deficiency with diabetes, hypertension, atherosclerosis, coronary heart disease (CHD), and cerebral vascular diseases [4,5,6]. This evidence concerns the gene ADIPOQ and atherosclerosis.